26 January 2017, London, UK
GaBI organized the ROUNDTABLE ON REGISTRIES: Practical Considerations for Registries – making them work on 26 January 2017 in London, UK in collaboration with the Association of the British Pharmaceutical Industry (ABPI).
The ROUNDTABLE ON REGISTRIES: Practical Considerations for Registries – making them work, was an interactive meeting with the participation of medical practitioners/specialists, such as dermatologists, gastroenterologists, who are key opinion leaders; academics, specialist nurses (inflammatory bowel disease, oncology, rheumatology), pharmacists (clinical, oncology), patient groups, regulators, audit group and industry representatives from the UK to discuss and exchange information with experts on the design, maintenance and utility of registries in medical practice including the perspective of pharmacovigilance. Forty participants, speakers included, attended the meeting.
The meeting focused on practical challenges of how to incorporate registry data collected in different formats; the role of industry sponsors specifically to pharmacovigilance programmes and how to access registry data; the use of registry data in clinical outcome research covering immunogenicity/adverse events of biologicals used, in building biologicals selection data; how can registries benefit patients; funding models of registries; how can registries improve pharmacovigilance activities; and how can registries improve health economics data research.
A meeting report of this roundtable has been published in GaBI Journal.
You can download the speakers’ presentations of this roundtable meeting:
Registers and Health Technology Assessment: a view from NICE
Linkage of registry and routine administrative datasets for pharmacoeconomic research
Patient perspective on biosimilars safety data and other concerns
Contact us for further information.
